Edition:
United Kingdom

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

695JPY
20 Nov 2017
Change (% chg)

¥13 (+1.91%)
Prev Close
¥682
Open
¥683
Day's High
¥695
Day's Low
¥671
Volume
292,400
Avg. Vol
320,992
52-wk High
¥1,020
52-wk Low
¥618

Chart for

About

NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The... (more)

Overall

Beta: 2.65
Market Cap(Mil.): ¥28,727.59
Shares Outstanding(Mil.): 43.20
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.24 16.44
EPS (TTM): -- -- --
ROI: -- 2.53 10.62
ROE: -- 3.17 14.20

BRIEF-VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan

* VBL Therapeutics and Nanocarrier Co Ltd sign exclusive agreement for VB-111 in Japan

06 Nov 2017

BRIEF-Nanocarrier signs exclusive agreement with VBL Therapeutics for VB-111 in Japan

* Says co signs an exclusive license agreement with VBL Therapeutics, for the development, commercialization, and supply of ofranergene obadenovec ("VB-111") in Japan

06 Nov 2017

BRIEF-NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

* Says it and NanoCarrier Co., Ltd conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

10 Oct 2017

BRIEF-NanoCarrier says orphan drug designation of NC-6004 by the U.S. FDA

* Says NC-6004, which is under development in the U.S. for biliary cancer, has been granted to the orphan drug designation from the U.S. FDA (Food and Drug Administration)

01 Aug 2017

BRIEF-NanoCarrier receives orphan drug designation from FDA

* Says its micellar nanoparticles preparation NC-6300 for soft tissue sarcomas has been designated to orphan drug by Food and Drug Administration (FDA) in U.S.

19 Jul 2017

BRIEF- NanoCarrier announces licenses contract with Todai TLO

* Says it signed a license contract with Todai TLO Ltd, regarding NC-6300 related high polymer micelle DDS

15 Jun 2017

Earnings vs. Estimates